Alkali Metals has received an Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for its Visakhapatnam Unit in Andhra Pradesh. The Visakhapatnam unit manufactures Active Pharmaceutical Ingredients (APIs) and other Chemical intermediates. The EIR from USFDA indicates closure of the inspection and that the Unit is in acceptable state of Compliance of Current Good Manufacturing Practice (CGMP).
Alkali Metals is engaged in the business of manufacturing sodium derivatives, pyridine derivatives and a range of fine chemicals, based on related chemistry.
